Filing metadata

Accession number
0001104659-23-101935
Form type
Form 3
Filer
NRX Pharmaceuticals, Inc.
CIK
CIK 1719406
Filed
Sep 19, 2023
Reporting period
Sep 13, 2023
Description
Initial ownership

Explore SEC Filings Hub